Jundishapur Journal of Microbiology

Published by: Kowsar

Cloning and Expression of Major Surface Antigen 1 Gene of Toxoplasma gondii RH Strain Using the Expression Vector pVAX1 in Chinese Hamster Ovary Cells

Rahman Abdizadeh 1 , 2 , Sharif Maraghi 2 , 3 , Ata A. Ghadiri 4 , * , Mehdi Tavalla 2 and Saeedeh Shojaee 5
Authors Information
1 Cell and Molecular Research Center, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Medical Parasitology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Institute of Health Research, Thalassemia and Hemoglobinopathy Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
4 Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
5 Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: March 01, 2015, 8 (3); e22570
  • Published Online: March 21, 2015
  • Article Type: Research Article
  • Received: August 5, 2014
  • Revised: September 30, 2014
  • Accepted: October 29, 2014
  • DOI: 10.5812/jjm.22570

To Cite: Abdizadeh R, Maraghi S, A. Ghadiri A, Tavalla M, Shojaee S. Cloning and Expression of Major Surface Antigen 1 Gene of Toxoplasma gondii RH Strain Using the Expression Vector pVAX1 in Chinese Hamster Ovary Cells, Jundishapur J Microbiol. 2015 ; 8(3):e22570. doi: 10.5812/jjm.22570.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Weiss LM, Kim K. Toxoplasma gondii : the model apicomplexan, perspectives and methods. 2014;
  • 2. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000; 30(12-13): 1217-58[DOI]
  • 3. Dubey JP. History of the discovery of the life cycle of Toxoplasma gondii. Int J Parasitol. 2009; 39(8): 877-82[PubMed]
  • 4. Elmore SA, Jones JL, Conrad PA, Patton S, Lindsay DS, Dubey JP. Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends Parasitol. 2010; 26(4): 190-6[DOI][PubMed]
  • 5. Jones JL, Dubey JP. Foodborne toxoplasmosis. Clin Infect Dis. 2012; 55(6): 845-51[DOI][PubMed]
  • 6. Izadi M, Jonaidi Jafari N, Mahmoodzadeh Poornaki A, Sadraei J, Rezavand B, Mirzaei HR, et al. Detection of Toxoplasma gondii from Clinical Specimens of Patients Receiving Renal Transplant Using ELISA and PCR. Nephrourol Mon. 2013; 5(5): 983-7[DOI][PubMed]
  • 7. Sarkari B, Shafiei R, Zare M, Sohrabpour S, Kasraian L. Seroprevalence and molecular diagnosis of Toxoplasma gondii infection among blood donors in southern Iran. J Infect Dev Ctries. 2014; 8(4): 543-7[DOI][PubMed]
  • 8. Chiang TY, Kuo MC, Chen CH, Yang JY, Kao CF, Ji DD, et al. Risk factors for acute Toxoplasma gondii diseases in Taiwan: a population-based case-control study. PLoS One. 2014; 9(3)[DOI][PubMed]
  • 9. Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013; 91(7): 501-8[DOI][PubMed]
  • 10. Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmadpour E, Shokri A, et al. Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Trop. 2014; 137: 185-94[DOI][PubMed]
  • 11. Munoz M, Liesenfeld O, Heimesaat MM. Immunology of Toxoplasma gondii. Immunol Rev. 2011; 240(1): 269-85[DOI][PubMed]
  • 12. Pereira-Chioccola VL, Vidal JE, Su C. Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients. Future Microbiol. 2009; 4(10): 1363-79[DOI][PubMed]
  • 13. Yan J, Huang B, Liu G, Wu B, Huang S, Zheng H, et al. Meta-analysis of prevention and treatment of toxoplasmic encephalitis in HIV-infected patients. Acta Trop. 2013; 127(3): 236-44[DOI][PubMed]
  • 14. Saadatnia G, Golkar M. A review on human toxoplasmosis. Scand J Infect Dis. 2012; 44(11): 805-14[DOI][PubMed]
  • 15. Paquet C, Yudin MH, Society of O, Gynaecologists of C. Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Can. 2013; 35(1): 78-81[PubMed]
  • 16. Chen J, Zhou DH, Li ZY, Petersen E, Huang SY, Song HQ, et al. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis. Exp Parasitol. 2014; 139: 42-8[DOI][PubMed]
  • 17. Meng M, Zhou A, Lu G, Wang L, Zhao G, Han Y, et al. DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c mice. BMC Infect Dis. 2013; 13: 494[DOI][PubMed]
  • 18. Zhang NZ, Chen J, Wang M, Petersen E, Zhu XQ. Vaccines against Toxoplasma gondii: new developments and perspectives. Expert Rev Vaccines. 2013; 12(11): 1287-99[DOI][PubMed]
  • 19. Garcia JL, Innes EA, Katzer F. Current progress toward vaccines against Toxoplasma gondii. Vaccine Dev Therap. 2014; 4(1): 23-8[DOI]
  • 20. Couvreur G, Sadak A, Fortier B, Dubremetz JF. Surface antigens of Toxoplasma gondii. Parasitology. 1988; 97 ( Pt 1): 1-10[PubMed]
  • 21. Grimwood J, Smith JE. Toxoplasma gondii: the role of parasite surface and secreted proteins in host cell invasion. Int J Parasitol. 1996; 26(2): 169-73[PubMed]
  • 22. Tomavo S, Schwarz RT, Dubremetz JF. Evidence for glycosyl-phosphatidylinositol anchoring of Toxoplasma gondii major surface antigens. Mol Cell Biol. 1989; 9(10): 4576-80[PubMed]
  • 23. Wang Y, Yin H. Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii. Parasit Vectors. 2014; 7: 180[DOI][PubMed]
  • 24. Sudan V, Tewari AK, Singh H. An Insight into the Behavior, Course and Kinetics of Acute Infection of Toxoplasma gondii Human RH Strain in Experimentally Infected Murine Model. Iran J Parasitol. 2014; 9(1): 114-9[PubMed]
  • 25. Cohen SN. Preparation and transformation of compete E. coli using calcium chloride. 2001; : 116-8
  • 26. Shevach EM. 2002; [DOI]
  • 27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259): 680-5[PubMed]
  • 28. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979; 76(9): 4350-4[PubMed]
  • 29. Okuda K, Wada Y, Shimada M. Recent Developments in Preclinical DNA Vaccination. Vaccines. 2014; 2(1): 89-106[DOI]
  • 30. Handman E, Goding JW, Remington JS. Detection and characterization of membrane antigens of Toxoplasma gondii. J Immunol. 1980; 124(6): 2578-83[PubMed]
  • 31. Mineo JR, Kasper LH. Attachment of Toxoplasma gondii to host cells involves major surface protein, SAG-1 (P30). Exp Parasitol. 1994; 79(1): 11-20[DOI][PubMed]
  • 32. Qu D, Wang S, Cai W, Du A. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice. Vaccine. 2008; 26(35): 4541-8[DOI][PubMed]
  • 33. Chen XG, Gong Y, Hua L, Lun ZR, Fung MC. High-level expression and purification of immunogenic recombinant SAG1 (P30) of Toxoplasma gondii in Escherichia coli. Protein Expr Purif. 2001; 23(1): 33-7[DOI][PubMed]
  • 34. Kazemi B, Bandehpour M, Maghen L, Solgi G. Gene Cloning of 30 kDa Toxoplasma gondii Tachyzoites Surface Antigen (SAG1). Iran J Parasitol. 2007; 2(2): 1-8
  • 35. Khanaliha K, Motazedian MH, Kazemi B, Shahriari B, Bandehpour M, Sharifniya Z. Evaluation of recombinant SAG1, SAG2, and SAG3 antigens for serodiagnosis of toxoplasmosis. Korean J Parasitol. 2014; 52(2): 137-42[DOI][PubMed]
  • 36. Solhjoo K, Ghaffari F, Dalimi-Asl A, Sharifi Z. Enhancement of Antibody Immune Response to a Toxoplasma gondii SAG1-Encoded DNA Vaccine by Formulation with Aluminum Phosphate. J Med Sci . 2007; 7(3): 361-7[DOI]
  • 37. Makioka A, Kobayashi A. Toxoplasmacidal activity of macrophages activated by recombinant major surface antigen (P30) of Toxoplasma gondii. Infect Immun. 1991; 59(8): 2851-2[PubMed]
  • 38. Nielsen HV, Lauemoller SL, Christiansen L, Buus S, Fomsgaard A, Petersen E. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun. 1999; 67(12): 6358-63[PubMed]
  • 39. Hoseinian Khosroshahi K, Ghaffarifar F, D'Souza S, Sharifi Z, Dalimi A. Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis. Vaccine. 2011; 29(4): 778-83[DOI][PubMed]
  • 40. Chuang SC, Ko JC, Chen CP, Du JT, Yang CD. Induction of long-lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles. Parasit Vectors. 2013; 6: 34[DOI][PubMed]
  • 41. Meng M, He S, Zhao G, Bai Y, Zhou H, Cong H, et al. Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice. Parasit Vectors. 2012; 5: 273[DOI][PubMed]
  • 42. Wu XN, Lin J, Lin X, Chen J, Chen ZL, Lin JY. Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice. Parasitol Res. 2012; 111(5): 2001-9[DOI][PubMed]
  • 43. Zhou H, Min J, Zhao Q, Gu Q, Cong H, Li Y, et al. Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant. Vaccine. 2012; 30(10): 1800-6[DOI][PubMed]
  • 44. Kozak M. Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene. 2005; 361: 13-37[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments